Cetera Investment Advisers Lowers Stock Holdings in Prestige Consumer Healthcare Inc. $PBH

Cetera Investment Advisers trimmed its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.7% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 5,093 shares of the company’s stock after selling 196 shares during the period. Cetera Investment Advisers’ holdings in Prestige Consumer Healthcare were worth $438,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in PBH. Bank of Montreal Can lifted its holdings in shares of Prestige Consumer Healthcare by 15.1% during the fourth quarter. Bank of Montreal Can now owns 7,127 shares of the company’s stock valued at $557,000 after purchasing an additional 937 shares during the last quarter. Sterling Capital Management LLC raised its holdings in Prestige Consumer Healthcare by 837.1% in the 4th quarter. Sterling Capital Management LLC now owns 1,593 shares of the company’s stock worth $124,000 after acquiring an additional 1,423 shares during the last quarter. Summit Investment Advisors Inc. raised its holdings in Prestige Consumer Healthcare by 4.2% in the 4th quarter. Summit Investment Advisors Inc. now owns 5,182 shares of the company’s stock worth $405,000 after acquiring an additional 211 shares during the last quarter. Barclays PLC raised its holdings in Prestige Consumer Healthcare by 20.8% in the 4th quarter. Barclays PLC now owns 111,689 shares of the company’s stock worth $8,721,000 after acquiring an additional 19,245 shares during the last quarter. Finally, Mariner LLC raised its holdings in Prestige Consumer Healthcare by 12.6% in the 4th quarter. Mariner LLC now owns 5,492 shares of the company’s stock worth $429,000 after acquiring an additional 615 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Up 0.7%

Shares of PBH stock opened at $65.06 on Monday. The stock has a market cap of $3.20 billion, a P/E ratio of 15.27, a PEG ratio of 2.05 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 52 week low of $62.95 and a 52 week high of $90.04. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The company’s fifty day simple moving average is $77.27 and its two-hundred day simple moving average is $81.62.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.06). The company had revenue of $249.53 million during the quarter, compared to analysts’ expectations of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The firm’s revenue for the quarter was down 6.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.90 EPS. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group decreased their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating for the company in a report on Friday, August 8th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.